SETTLEMENT AGREEMENTSettlement Agreement • June 26th, 2013 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • New York
This Settlement Agreement and Mutual Release (hereinafter "Settlement Agreement") is entered into effective as of March __, 2013 (“Effective Date”) by and between Oxygen Biotherapeutics, Inc. (“OBI”) and Tenor Opportunity Master Fund, Ltd., Aria Opportunity Fund, Ltd. and Parsoon Opportunity Fund, Ltd. (collectively "Tenor"), both of which are sometimes collectively referred to as the "Parties" and is made with reference to the following:
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • June 26th, 2013 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • North Carolina
THIS LICENSE AND SUPPLY AGREEMENT ("Agreement") is by and between Oxygen Biotherapeutics, Inc., with a place of business at ONE Copley Parkway, Suite 490, Morrisville, North Carolina 27560 ("OBI" or "Licensor"), and Valor SA (Cosmetics Division), with a place of business at Boulevard de Grancy 1 – CH1006 Lausanne - Switzerland, ("VCD" or "Licensee"), (each individually referred to herein as a “Party” and collectively referred to as the “Parties”).
